Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00336739 · ClinicalTrials.gov registry record · NA

The Effect of Cinacalcet on Gastric Acid Output in Healthy Subjects

A NA study of Healthy, sponsored by Tufts University.

Completed
Registry status
NA
Development phase
17
Enrollment target
1
Study location

NCT00336739: Completed NA study of Healthy, sponsored by Tufts University.

NCT00336739 is a NA study of Healthy that has completed, run by Tufts University. The registered enrollment target is 17 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00336739, a NA study of Healthy, has completed, sponsored by Tufts University.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether cinacalcet will increase gastric acid secretion in healthy volunteers.

Conditions Studied

Interventions

  • DRUG cinacalcet

Study Locations (1)

Massachusetts

  • Human Nutrition Research Center on Aging at Tufts University - Boston

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2006-04
Est. Completion 2007-03
Phase NA
Tufts University

163 total trials

What the finished NCT00336739 record still lists

NCT00336739 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which cinacalcet is the first listed.

NCT00336739 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00336739 about?

NCT00336739 is a clinical study titled "The Effect of Cinacalcet on Gastric Acid Output in Healthy Subjects". The purpose of this study is to determine whether cinacalcet will increase gastric acid secretion in healthy volunteers.

What is the current status of trial NCT00336739?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2006-04. Estimated completion is 2007-03.

What conditions does trial NCT00336739 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00336739?

The interventions under investigation include: cinacalcet (DRUG).

Who is sponsoring clinical trial NCT00336739?

This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00336739 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00336739's enrollment target sits among peer trials

17 929th of 1090 higher than 156 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00336739, the US trial registry maintained by the National Library of Medicine. NCT00336739 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.